GERON CORP

GERN NASDAQ

MarketShogun

Seeing some call buying on this for JAN, looking for a bottom.

MisterWilford

Price Target: 2.40

a2zdchanels

GERN bullish macd cross over. target range: $2-$2.24

PennyStock101

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Chart-read

New management, improvement in balance sheets convinced me. Sector is also outperforming. And now cup with handle pattern setup on chart. Looks like There is a strong resistance at current price, But I'm bullish. Target price = $4.5.

SETTOUTI-ahmed-expert

scalping buy

PennyStock101

If you fancy a flutter, GERN could be a great place to start, option traders are expecting a move of up to $40 % on Monday as a result of the outcome from the Phase Data results been released tomorrow at the HOC conference. Like any Bio stock it is risky to trade but can be very rewarding,so play carefully. AVERAGE ANALYSTS PRICE TARGET $3.5 AVERAGE ANALYSTS...

zhoodtrades

PM for details or to criticize.

PennyStock101

Geron Group has been on a explosive move forward in 2019 and like many Pharmaceutical companies it is moving on very little publicly released news. We have a alert on the stock for a break of $2.40 where it meets resistance and the 200ma with a major gap above.

TeeMiner

Sitting @ the bottom with lot of room to grow.

NickFi

GERN dropped very badly in premarket today because of some bad news involving Johnson & Johnson's (NYSE:JNJ) Janssen unit. I was curious to see if there was any insider trading in the days before the news was released. I found out there were two transactions, both of the director and the secretary sold a total of $7 million dollars in late August - middle...

DigitalMoneyTraders

Cup and Handle target $10

TradersArticle

This stock has been in our watchlist for a few weeks now. From the last pullback we had last week and a tested level on the demand zone, we are now more convince with this as one with potential growth. With JNJ as a backing, let's hope this happen.

01:51

kizer777

watch video for details

Shortmetina

Possible Double Bottom at $5.10 Stock looks like its ready to run and run fast If $5.10 can represent the low going forward, we break above multi-year resistance of $6.50 and hold; might get a double here! Time will tell.

NaughtyPines

... for a 3.22 debit. Max Profit: $78/contract Max Loss/Buying Power Effect: $322 per contract Break Even/Cost Basis: 3.22/share Notes: A speculative shot on a high implied volatility biotech underlying ... .

Shortmetina

9 year channel another attempt at breaking resistance If we can break resistance, price tgt: $10+

Kuvira

there has been so much good news about this company it must still be breaking out.. high volume above all moving averages and the macd and momentum indicators all say it's good